SEC Form 4 · accession 0001127602-18-035269
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Bertolini
Director
Period of report
Dec 4, 2018
Accepted (ET)
Dec 6, 2018 · 8:31 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 4, 2018 | S | 100 | $134.19 | D | 26,336 | D | |
| Common Stock | Dec 4, 2018 | S | 100 | $134.365 | D | 26,236 | D | |
| Common Stock | Dec 4, 2018 | S | 100 | $134.465 | D | 26,136 | D | |
| Common Stock | Dec 4, 2018 | S | 200 | $134.49 | D | 25,936 | D | |
| Common Stock | Dec 4, 2018 | S | 100 | $134.50 | D | 25,836 | D | |
| Common Stock | Dec 4, 2018 | S | 100 | $135.01 | D | 25,736 | D | |
| Common Stock | Dec 4, 2018 | S | 100 | $135.03 | D | 25,636 | D | |
| Common Stock | Dec 4, 2018 | S | 100 | $135.04 | D | 25,536 | D | |
| Common Stock | Dec 4, 2018 | S | 100 | $135.06 | D | 25,436 | D | |
| Common Stock | Dec 4, 2018 | S | 100 | $135.15 | D | 25,336 | D |
Table II — derivative securities
No Table II lines on this filing.